Estimating the number of people prescribed PrEP
Bianca Sepulveda made this Official Information request to Pharmaceutical Management Agency
The request was successful.
From: Bianca Sepulveda
Dear Pharmaceutical Management Agency,
I would be grateful for any information related to the number of people that have been prescribed PrEP (Tenofovir and Emtricitabine) in Aotearoa New Zealand since it became funded on April 1, 2018.
Any information would be appreciated, for example, the number of people prescribed PrEP in 2018, 2019, or 2020 would be useful.
Many thanks
Bianca Sepulveda
From: Web Enquiry
Pharmaceutical Management Agency
Thank you for emailing PHARMAC enquiries.
o [1]View a list of all currently funded medicines (the Pharmaceutical
Schedule)
o [2]View the progress of funding applications on the Application
Tracker
o [3]Read our latest COVID-19 update
We will endeavour to get back to you within two working days.
Ngā mihi,
PHARMAC Enquiries
This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.
References
Visible links
1. https://pharmac.govt.nz/pharmaceutical-s...
2. https://connect.pharmac.govt.nz/apptrack...
3. https://pharmac.govt.nz/news-and-resourc...
From: Web Enquiry
Pharmaceutical Management Agency
Ahiahi marie Bianca
You may find the data available through the publicly available
[1]pharmaceutical data web tool useful:
[2]https://minhealthnz.shinyapps.io/pharmac...
This web tool allows users to see the number of people prescribed and/or
dispensed medicines up to 2019 in Aotearoa.
For example
Type of measure: prescription
Level of data presented: chemical
Show: selected pharmaceuticals only (emtricitabine with tenofovir
disoproxil)
Geographical breakdown: New Zealand
Additionally, we have responded to several OIA requests recently regarding
PrEP which you may find useful.
o 8 March 2021:
[3]https://pharmac.govt.nz/about/what-we-do...
o 15 February 2021:
[4]https://pharmac.govt.nz/about/what-we-do...
o 5 February 2021:
[5]https://pharmac.govt.nz/about/what-we-do...
o 17 March 2020:
[6]https://pharmac.govt.nz/about/what-we-do...
Please let us know if you require any further assistance or are looking
for any more specific information.
Ngā mihi
Melody Willis ([7]she/her) | Government Services Adviser
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[8]www.pharmac.govt.nz
show quoted sections
From: Bianca Sepulveda
Hi Melody,
Many thanks for your reply and the helpful links.
The webtool you mentioned does not differentiate between initial and renewal applications. Would there be any recent data available for the number of approved Special Authority applications (both initial and renewal applications) of emtricitabine with tenofovir disporoxil for the use of pre-exposure prophylaxis (PrEP)?
In particular, I'd be very grateful for any data you might have on this:
a) at a national level
b) in the Wellington (CCDHB) region
Thank you for any help you are able to offer with this,
Bianca Sepulveda
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Bianca
I am happy to log this as a request with our Analysis team to see what information they are able to provide.
What time frame are you looking for information within?
Ngā mihi
Melody Willis (she/her) | Government Services Adviser
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
show quoted sections
From: Bianca Sepulveda
Hi Melody,
Thanks very much for the reply. Ideally it would be great to have this information by the end of the week, but I understand that this is a tight time-frame. If it comes in after that time it will still be very helpful.
With many thanks,
Bianca
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Bianca
My apologies, I meant what time frame of information are you looking for,
eg 2019/20 financial year, etc?
Your request (in italics below) has been received and logged. Our
reference number for your request is 2020-21-148.
As required under the Official Information Act 1982, we will respond to
your request within 20 working days.
If a large amount of information has been requested, we may need to extend
this date (this is provided for in section 15A of the Act). We will advise
you if such an extension is necessary.
Ngā mihi
Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
show quoted sections
From: Bianca Sepulveda
Hi Melody,
My mistake, apologies!
Any recent time frame would be good, eg 2020 if possible.
I'm also particular interested in data specifically from the Wellington region if at all possible?
Many thanks,
Bianca
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Bianca
Thanks for confirming those details.
I have submitted your request for the number of approved Special Authority
applications (both initial and renewal applications) of emtricitabine with
tenofovir disoproxil for the use of pre-exposure prophylaxis (PrEP), for
any recent time frame... eg 2020. In particular:
• at a national level
• in the Wellington (CCDHB) region
You should receive a response on or before 23 June 2021.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[2]www.pharmac.govt.nz
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
2020 21 148 2021 06 11 OIA response letter Special Authority approval data for emtricitabine with tenofovir disoproxil only.pdf
128K
Download
View as HTML
2020 21 148 Special Authority approval data for emtricitabine with tenofovir disoproxil only.xlsx
41K
Download
View as HTML
Kia ora Bianca
Please find attached a response to your recent request for information.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[2]www.pharmac.govt.nz
From: Web Enquiry
Sent: Wednesday, 26 May 2021 1:26 pm
To: 'Bianca Sepulveda' <[FOI #15323 email]>
Subject: RE: Official Information request - Estimating the number of
people prescribed PrEP
Kia ora Bianca
Thanks for confirming those details.
I have submitted your request for the number of approved Special Authority
applications (both initial and renewal applications) of emtricitabine with
tenofovir disoproxil for the use of pre-exposure prophylaxis (PrEP), for
any recent time frame... eg 2020. In particular:
• at a national level
• in the Wellington (CCDHB) region
You should receive a response on or before 23 June 2021.
Ngā mihi
Melody Willis ([3]she/her) | Government Services Advisor
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[4]www.pharmac.govt.nz
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this requestAct on what you've learnt
Similar requests
Decision not to provide information to Today FM or Mediaworks
To Pharmaceutical Management Agency by New Zealand Council for Civil Liberties
